Pages that link to "Q44843167"
Jump to navigation
Jump to search
The following pages link to Pentosidine effects on human osteoblasts in vitro. (Q44843167):
Displaying 50 items.
- Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions (Q26750574) (← links)
- O-GlcNAcylation: a bridge between glucose and cell differentiation (Q26765379) (← links)
- Childhood obesity, bone development, and cardiometabolic risk factors (Q26853091) (← links)
- The alliance of mesenchymal stem cells, bone, and diabetes (Q27012497) (← links)
- Advanced glycation end products play adverse proinflammatory activities in osteoporosis (Q27024641) (← links)
- Advanced glycation end products and diabetic complications (Q27687501) (← links)
- Mechanisms of diabetes mellitus-induced bone fragility (Q30241947) (← links)
- Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. (Q33901933) (← links)
- Focal therapeutic irradiation induces an early transient increase in bone glycation. (Q35245623) (← links)
- Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner (Q35795868) (← links)
- Arthroplasty in veterans: Analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes (Q35804646) (← links)
- Bone fragility in type 2 diabetes mellitus (Q35825346) (← links)
- Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men. (Q35963018) (← links)
- Influence of high glucose and advanced glycation end-products (ages) levels in human osteoblast-like cells gene expression. (Q36119266) (← links)
- Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties (Q36372679) (← links)
- Determinants of bone strength and quality in diabetes mellitus in humans (Q36373016) (← links)
- Diabetes and Its Effect on Bone and Fracture Healing. (Q36407732) (← links)
- Advanced Glycation End-products and Bone Fractures (Q36868071) (← links)
- Bone quality in diabetes (Q36927957) (← links)
- Bone metabolism and fracture risk in type 2 diabetes mellitus (Q37056305) (← links)
- Bone mechanical properties and changes with osteoporosis (Q37113961) (← links)
- RAGE and its ligands in bone metabolism. (Q37274344) (← links)
- Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus (Q37598559) (← links)
- A review of rodent models of type 2 diabetic skeletal fragility (Q37650212) (← links)
- Increased levels of circulating advanced glycation end-products in menopausal women with osteoporosis (Q37673039) (← links)
- Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis (Q37790176) (← links)
- Review: The Diabetic Bone: A Cellular and Molecular Perspective (Q37858842) (← links)
- Bone metabolism and fracture risk in type 2 diabetes mellitus [Review] (Q37903586) (← links)
- Type 2 diabetes and bone (Q38048186) (← links)
- Antidiabetic therapy effects on bone metabolism and fracture risk (Q38078009) (← links)
- Impact of diabetes and its treatments on skeletal diseases (Q38078839) (← links)
- Diabetes, collagen, and bone quality (Q38195566) (← links)
- Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease (Q38384409) (← links)
- Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition (Q38776127) (← links)
- DXA-Based Measurements in Diabetes: Can They Predict Fracture Risk? (Q38945656) (← links)
- Bone disease in diabetes: another manifestation of microvascular disease? (Q39331184) (← links)
- Bone cells and bone turnover in diabetes mellitus (Q41294180) (← links)
- The impact of type 2 diabetes on bone metabolism (Q42660007) (← links)
- Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients (Q44414030) (← links)
- Association of the glycoxidative stress marker pentosidine with equine laminitis. (Q45004079) (← links)
- Effects of dietary bread crust Maillard reaction products on calcium and bone metabolism in rats (Q46042155) (← links)
- Dietary Advanced Glycation End Products have Sex-and Age Dependent Effects on Vertebral Bone Microstructure and Mechanical Function in Mice (Q47327491) (← links)
- Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools (Q49667245) (← links)
- Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes (Q50223052) (← links)
- Bone Formation is Affected by Matrix Advanced Glycation End Products (AGEs) In Vivo (Q51311945) (← links)
- Feasibility of Serum Pentosidine Level as a Potential Risk Factor for Osteoporotic Vertebral Compression Fracture (Q57455729) (← links)
- Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies (Q58577346) (← links)
- Obtaining Pentosidine Levels as an Adjunct to Determine a Patient's Candidacy for Vertebral Stabilization for a Vertebral Compression Fracture (Q64077476) (← links)
- Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties (Q64230394) (← links)
- In Silico Interaction of the Active Compounds of Scurrula Atropurpurea with the RANK/RANKL/OPG System in Diabetoporosis. (Q64939426) (← links)